Jubilant Ingrevia has raised Rs 50 crore through Commercial Papers (‘CPs’) on February 02. Date of maturity of the said Commercial Papers is March 27, 2024. Tenure of the instrument is 54 days. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 50 crore.
The Finance Committee, at its meeting held on August 18, 2023 approved issuance of Commercial Papers up to an amount of Rs 600 crore outstanding at any point of time, in one or more tranches.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
